Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.

Lorenzo, Giuseppe Di; Rea, Antonio; Carlomagno, Chiara; Pepe, Stefano; Palmieri, Giovannella; Labianca, Roberto; Chirianni, Antonio; Stefano, Alfonso De; Esposito, Vincenzo; Placido, Sabino De

doi:10.3748/wjg.v13.i48.6553

Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.

NobleIDNI6P08W16R26S33

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F0BCF70C.svg?ark=w1%2F20260515%2FF0BCF70C&value=id)](https://nobleid.org/work/w1/20260515/F0BCF70C)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.

NobleIDNI6P08W16R26S33

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F0BCF70C.svg?ark=w1%2F20260515%2FF0BCF70C&value=id)](https://nobleid.org/work/w1/20260515/F0BCF70C)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work